NCT01442181

Brief Summary

The purpose of this study is to compare a minimally invasive surgical procedure and medication management in stroke patients with Atrial Fibrillation. The two treatment options are a minimally invasive surgical procedure or the use of medications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable atrial-fibrillation

Timeline
Completed

Started Mar 2010

Longer than P75 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 5, 2010

Completed
12 months until next milestone

First Posted

Study publicly available on registry

September 28, 2011

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
9 months until next milestone

Results Posted

Study results publicly available

July 23, 2015

Completed
Last Updated

July 23, 2015

Status Verified

July 1, 2015

Enrollment Period

3.7 years

First QC Date

October 5, 2010

Results QC Date

February 24, 2015

Last Update Submit

July 17, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of Life RAND 36-Item Health Survey

    Compare quality of life of patient satisfaction between the surgery and or the medication in stroke patients with AF (atrial fibrillation). The RAND 36-Item Health Survey taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. Note that all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. Items in the same scale are averaged together to create the 8 scale scores which will have a 0 to 100 range.

    Change in baseline, 3 month, and 6 month

Other Outcomes (9)

  • STAI-FormY-1 Questionnaire (State-Trait Anxiety Inventory)

    Change in baseline, 3 month, and 6 month

  • STAI-Form-Y2 Questionnaire (State-Trait Anxiety Inventory)

    Change in baseline, 3 month, and 6 month

  • Montreal Cognitive Assessment (Moca)

    Change in baseline, 3 month, and 6 month

  • +6 more other outcomes

Study Arms (2)

Minimally Invasive Surgery

ACTIVE COMPARATOR

Thumb sized incisions are made on each sides of the chest wall where instruments are placed in the chest to perform the surgery.

Procedure: Minimally Invasive Surgery

Medical Therapy

ACTIVE COMPARATOR

Patients are treated with rhythm and rate control medications.

Other: Medical therapy

Interventions

Small thumb sized incisions are made on each side of the chest wall where instruments are inserted for the purpose of completing the surgery.

Also known as: Minimally Invasive Maze Procedure
Minimally Invasive Surgery

Patients are treated with rhythm and rate control medications.

Also known as: Medical Management
Medical Therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a history of stroke and paroxysmal, persistent or permanent AF.
  • Eligible symptoms INCLUDE hemiplegia or hemiparesis, monoplegia, or language disturbance other than isolated dysarthria.
  • Symptoms that will NOT QUALIFY AS TIA INCLUDE transient monocular blindness in both eyes, dysarthria, vertigo,isolated sensory symptoms, confusion, memory loss, nonspecific complaints of dizziness, or syncope.

You may not qualify if:

  • Recent stroke (\< 1 month).
  • Age \< 18 or \> 80 years; Ejection Fraction \< 25%• Presence of left atrial appendage thrombus on CT or echocardiography
  • Previous empyema or thoracic surgery, preventing access to the pulmonary veins via thoracoscopy.
  • Left Atrial Diameter \> 55mm.
  • Contraindication to anticoagulation with Coumadin.
  • Mitral insufficiency (\> 2+)
  • • Contraindications to MRI
  • Artificial heart valve prosthesis
  • Aneurysm clips
  • Implanted drug infusion device or pump
  • Any type of neurotranstimulator
  • Any type of bone growth stimulator
  • Cochlear implants or inner ear prosthesis
  • Any intravascular coils, filters, or stents
  • Shrapnel or bullets
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Gainesville, Florida, 32610, United States

Location

MeSH Terms

Conditions

Atrial FibrillationStroke

Interventions

Minimally Invasive Surgical ProceduresNutrition TherapyPractice Management, Medical

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeTherapeuticsPractice ManagementProfessional PracticeOrganization and AdministrationHealth Services Administration

Results Point of Contact

Title
Dr. Thomas Beaver
Organization
UF Healthcare

Study Officials

  • Thomas Beaver, MD

    University of Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2010

First Posted

September 28, 2011

Study Start

March 1, 2010

Primary Completion

November 1, 2013

Study Completion

November 1, 2014

Last Updated

July 23, 2015

Results First Posted

July 23, 2015

Record last verified: 2015-07

Locations